Matches in Wikidata for { <http://www.wikidata.org/entity/Q92623963> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q92623963 description "article scientifique publié en 2019" @default.
- Q92623963 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92623963 description "scientific article published on 09 June 2019" @default.
- Q92623963 description "wetenschappelijk artikel" @default.
- Q92623963 description "наукова стаття, опублікована 9 червня 2019" @default.
- Q92623963 name "Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2" @default.
- Q92623963 name "Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2" @default.
- Q92623963 type Item @default.
- Q92623963 label "Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2" @default.
- Q92623963 label "Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2" @default.
- Q92623963 prefLabel "Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2" @default.
- Q92623963 prefLabel "Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2" @default.
- Q92623963 P1433 Q92623963-0408FBFA-B02D-4DA1-9DE6-09CE6F1B5D3D @default.
- Q92623963 P1476 Q92623963-73BD8C2F-D3A3-4AE9-BF9F-9913811782BF @default.
- Q92623963 P2093 Q92623963-05085BE6-1685-4209-A6ED-507B7804261F @default.
- Q92623963 P2093 Q92623963-34793161-E491-4054-B5D9-3225A5B0786B @default.
- Q92623963 P2093 Q92623963-44E56D32-C72A-436F-AC34-53A07B230B94 @default.
- Q92623963 P2093 Q92623963-5410D579-1515-47A2-9C3E-A0E65ACC3A12 @default.
- Q92623963 P2093 Q92623963-6C9D543B-A19A-439A-B960-AC32F0EF6F99 @default.
- Q92623963 P2093 Q92623963-6D64B470-941F-4F56-8290-708D12407BE6 @default.
- Q92623963 P2093 Q92623963-7C9A03E0-E8C1-4D83-BBB7-F55E5E574034 @default.
- Q92623963 P2093 Q92623963-87D01F62-AA97-41D4-A2DA-178CECA654B5 @default.
- Q92623963 P2093 Q92623963-9279AE8C-F1BE-4253-BD0C-C95B2A1B73F4 @default.
- Q92623963 P2093 Q92623963-A3510E52-6D43-48FD-AF78-53957C64C0B8 @default.
- Q92623963 P2093 Q92623963-CF305C84-4D21-439D-B52E-7F379B9EBA8B @default.
- Q92623963 P2093 Q92623963-D092D818-039A-450C-A1BD-5B23EDB71915 @default.
- Q92623963 P2093 Q92623963-DAE5DB9E-A67A-4596-AD2F-40836F7163C2 @default.
- Q92623963 P2093 Q92623963-EC06ACC7-F9D0-4E0F-B3C4-3C8BE6B01EA3 @default.
- Q92623963 P275 Q92623963-B39EAEC8-EACE-462C-906B-481CED89E1AB @default.
- Q92623963 P304 Q92623963-E2709C23-2906-4D53-AE30-ECD303CC2592 @default.
- Q92623963 P31 Q92623963-B63634F3-097E-4DFB-9215-A0F70219DB6A @default.
- Q92623963 P356 Q92623963-62201098-F09D-4A2F-948E-00C64BBE5731 @default.
- Q92623963 P50 Q92623963-04659CC8-79AD-497D-97CF-23A031D29430 @default.
- Q92623963 P50 Q92623963-0B47A22A-0CBA-4290-AEFB-1595EF7D03F6 @default.
- Q92623963 P50 Q92623963-B99704E7-0B1D-4C64-BAF2-C8A49506693E @default.
- Q92623963 P577 Q92623963-B637F52A-3574-42FD-8258-1832CFB00162 @default.
- Q92623963 P6216 Q92623963-D90AA52C-3128-4185-9BCB-086D6D063895 @default.
- Q92623963 P698 Q92623963-104E4278-5FDF-413D-A67C-378D22F2E310 @default.
- Q92623963 P921 Q92623963-5BFE399B-0B64-42D6-9849-2AF08FAA7CBB @default.
- Q92623963 P356 09546634.2019.1612836 @default.
- Q92623963 P698 31179791 @default.
- Q92623963 P1433 Q6295084 @default.
- Q92623963 P1476 "Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2" @default.
- Q92623963 P2093 "Abhijit Gadkari" @default.
- Q92623963 P2093 "Andreas Wollenberg" @default.
- Q92623963 P2093 "Anita Remitz" @default.
- Q92623963 P2093 "April Armstrong" @default.
- Q92623963 P2093 "Eric L Simpson" @default.
- Q92623963 P2093 "Giampiero Girolomoni" @default.
- Q92623963 P2093 "Jingdong Chao" @default.
- Q92623963 P2093 "Laurent Eckert" @default.
- Q92623963 P2093 "Marius Ardeleanu" @default.
- Q92623963 P2093 "Marjolein de Bruin-Weller" @default.
- Q92623963 P2093 "Stefan Beissert" @default.
- Q92623963 P2093 "Vera Mastey" @default.
- Q92623963 P2093 "Yoko Kataoka" @default.
- Q92623963 P2093 "Zhen Chen" @default.
- Q92623963 P275 Q24082749 @default.
- Q92623963 P304 "1-9" @default.
- Q92623963 P31 Q13442814 @default.
- Q92623963 P356 "10.1080/09546634.2019.1612836" @default.
- Q92623963 P50 Q42669207 @default.
- Q92623963 P50 Q44605049 @default.
- Q92623963 P50 Q45287273 @default.
- Q92623963 P577 "2019-06-09T00:00:00Z" @default.
- Q92623963 P6216 Q50423863 @default.
- Q92623963 P698 "31179791" @default.
- Q92623963 P921 Q268667 @default.